E. Cohen-Jonathan Moyal

958 total citations
25 papers, 355 citations indexed

About

E. Cohen-Jonathan Moyal is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, E. Cohen-Jonathan Moyal has authored 25 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in E. Cohen-Jonathan Moyal's work include Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). E. Cohen-Jonathan Moyal is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). E. Cohen-Jonathan Moyal collaborates with scholars based in France, United States and Italy. E. Cohen-Jonathan Moyal's co-authors include V. Lubrano, Sylvie Monferran, Anthony Lemarié, Perrine Dahan, Laure Malric, Christine Toulas, Caroline Delmas, Jonathan Khalifa, Emmanuelle Uro‐Coste and Jean-Baptiste Clavier and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

E. Cohen-Jonathan Moyal

25 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Cohen-Jonathan Moyal France 7 239 108 102 98 81 25 355
Mart A. A. M. Heesters Netherlands 8 235 1.0× 98 0.9× 104 1.0× 97 1.0× 69 0.9× 10 472
Despina Misailidou Greece 8 278 1.2× 183 1.7× 92 0.9× 65 0.7× 75 0.9× 9 417
J.A. MacKinnon Canada 3 232 1.0× 86 0.8× 76 0.7× 50 0.5× 79 1.0× 3 315
Nazia F. Jafri United States 8 222 0.9× 106 1.0× 162 1.6× 122 1.2× 97 1.2× 13 462
J. Curschmann Switzerland 4 331 1.4× 172 1.6× 67 0.7× 58 0.6× 65 0.8× 6 431
Richard Zuniga United States 6 360 1.5× 211 2.0× 121 1.2× 89 0.9× 141 1.7× 16 498
Dror Limon Israel 11 162 0.7× 166 1.5× 45 0.4× 147 1.5× 48 0.6× 45 395
Jethro Hu United States 13 295 1.2× 85 0.8× 139 1.4× 93 0.9× 112 1.4× 34 471
Linbo Cai China 10 113 0.5× 165 1.5× 80 0.8× 117 1.2× 103 1.3× 75 337
Shaio Woo United States 4 157 0.7× 131 1.2× 142 1.4× 60 0.6× 41 0.5× 4 364

Countries citing papers authored by E. Cohen-Jonathan Moyal

Since Specialization
Citations

This map shows the geographic impact of E. Cohen-Jonathan Moyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Cohen-Jonathan Moyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Cohen-Jonathan Moyal more than expected).

Fields of papers citing papers by E. Cohen-Jonathan Moyal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Cohen-Jonathan Moyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Cohen-Jonathan Moyal. The network helps show where E. Cohen-Jonathan Moyal may publish in the future.

Co-authorship network of co-authors of E. Cohen-Jonathan Moyal

This figure shows the co-authorship network connecting the top 25 collaborators of E. Cohen-Jonathan Moyal. A scholar is included among the top collaborators of E. Cohen-Jonathan Moyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Cohen-Jonathan Moyal. E. Cohen-Jonathan Moyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suc, Bertrand, E. Cohen-Jonathan Moyal, Jean‐Marie Péron, et al.. (2024). Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities. Clinical and Translational Radiation Oncology. 50. 100892–100892. 1 indexed citations
2.
Stefan, Dinu, Justine Lequesne, Delphine Larrieu‐Ciron, et al.. (2023). Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade glioma patients: OLA-TMZ-RTE-01.. Journal of Clinical Oncology. 41(16_suppl). 2046–2046. 1 indexed citations
3.
Pïcca, Alberto, Anna Luisa Di Stefano, Julien Savatovsky, et al.. (2023). CTNI-33. TARGET TRIAL: A PHASE I/II OPEN-LABEL MULTICENTER STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFICACY OF AZD4547 IN PATIENTS WITH RELAPSED/REFRACTORY FGFR FUSION POSITIVE GLIOMA. Neuro-Oncology. 25(Supplement_5). v81–v81. 2 indexed citations
4.
Vidal, Chrystelle, Olivier Chinot, E. Cohen-Jonathan Moyal, et al.. (2022). Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study. The Oncologist. 27(5). 414–423. 4 indexed citations
5.
Cabarrou, Bastien, Thibaud Valentin, Eberhard Stoeckle, et al.. (2021). Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment. Strahlentherapie und Onkologie. 197(12). 1051–1062. 4 indexed citations
6.
Roth, Patrick, Andrea Pace, Émilie Le Rhun, et al.. (2020). Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up. Annals of Oncology. 32(2). 171–182. 39 indexed citations
7.
Modesto, A., C. Chira, Jean Christophe Sol, et al.. (2019). Prise en charge des patients atteints de métastases cérébrales de mélanome. Cancer/Radiothérapie. 23(2). 147–150. 5 indexed citations
8.
Bayart, Émilie, D. Azria, Jacques Balosso, et al.. (2019). RadioTransNet, le réseau national de radiothérapie oncologique préclinique. Cancer/Radiothérapie. 23(6-7). 609–616. 5 indexed citations
9.
Tensaouti, Fatima, E. Martin, Franck Desmoulin, et al.. (2019). PO-0957 Radiomics study from the dose-painting multicenter phase III trial on newly diagnosed glioblastoma. Radiotherapy and Oncology. 133. S518–S519. 1 indexed citations
10.
Chaltiel, Léonor, et al.. (2017). Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation. Journal of Neuro-Oncology. 136(2). 413–419. 5 indexed citations
11.
Khalifa, Jonathan, Fatima Tensaouti, Amélie Lusque, et al.. (2017). Subventricular zones: new key targets for glioblastoma treatment. Radiation Oncology. 12(1). 67–67. 32 indexed citations
12.
Tabouret, Émeline, Anh Tuấn Nguyễn, Caroline Dehais, et al.. (2016). Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Acta Neuropathologica. 132(4). 625–634. 78 indexed citations
13.
Laprie, Anne, et al.. (2015). SP-0363: Predictive value of MR spectroscopic imaging for relapse site in GBM and integration in a dose-painting trial. Radiotherapy and Oncology. 115. S175–S176. 1 indexed citations
14.
Dahan, Perrine, Caroline Delmas, Sylvie Monferran, et al.. (2014). Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death and Disease. 5(11). e1543–e1543. 123 indexed citations
15.
Moyal, E. Cohen-Jonathan, M. Delannes, Laëtitia Padovani, et al.. (2013). Radiothérapie des tumeurs cérébrales : quelles marges ?. Cancer/Radiothérapie. 17(5-6). 434–443. 10 indexed citations
16.
Moyal, E. Cohen-Jonathan. (2012). Du laboratoire vers la clinique : expérience du glioblastome pour moduler la radiosensibilité tumorale. Cancer/Radiothérapie. 16(1). 25–28. 3 indexed citations
17.
Ken, S., L. Vieillevigne, X. Franceries, et al.. (2012). 209 MR SPECTROSCOPY IMAGING (MRSI) FOR GLIOBLASTOMA DOSE PAINTING WITH INTENSITY MODULATED RADIATION THERAPY COMPRISING SIMULTANEOUS INTEGRATED BOOST ON SPECIFIC TARGETS. Radiotherapy and Oncology. 102. S103–S105. 1 indexed citations
18.
Moyal, E. Cohen-Jonathan. (2009). Thérapies antiangiogéniques et radiothérapie : du concept à l’essai clinique. Cancer/Radiothérapie. 13(6-7). 562–567. 6 indexed citations
19.
Moyal, E. Cohen-Jonathan, Isabelle Ader, Caroline Delmas, et al.. (2009). Targeting FGFR-1 Pathways by the Antagonist SSR128129E Overcomes the Radioresistance of Human Glioma In Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 75(3). S70–S70. 1 indexed citations
20.
Moyal, E. Cohen-Jonathan. (2008). Optimizing antiangiogenic strategies: combining with radiotherapy. Targeted Oncology. 3(1). 51–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mart A. A. M. Heesters Breakdown of academic impact, for papers by Despina Misailidou Breakdown of academic impact, for papers by J.A. MacKinnon Breakdown of academic impact, for papers by Nazia F. Jafri Breakdown of academic impact, for papers by J. Curschmann Breakdown of academic impact, for papers by Richard Zuniga Breakdown of academic impact, for papers by Dror Limon Breakdown of academic impact, for papers by Jethro Hu Breakdown of academic impact, for papers by Linbo Cai Breakdown of academic impact, for papers by Shaio Woo
Rankless by CCL
2026